Connecticut State Department of Public Health

Beginning Nov. 20, 2023, every U.S. household can again place an order to receive four more free COVID-19 rapid tests delivered to their home by visiting COVIDTests.gov. If you did not order tests this fall, you may place two orders for a total of eight tests. Additionally, before you discard any “expired” test kits you have, please check here to see if the expiration dates of your COVID-19 tests have been extended.

COVID-19 Therapeutic Treatments

Treatment for COVID-19 can help prevent hospitalization and reduce your chance for severe disease.  Call your doctor right away to learn about your treatment options.

The U.S. Food and Drug Administration (FDA) authorized emergency use of two oral antiviral therapeutics and has approved the use of one monoclonal antibody therapeutic for the treatment of patients with COVID-19. These treatments have been shown to reduce hospitalization and deaths in high risk COVID-19 patients with mild to moderate symptoms.

This webpage is updated with the latest therapeutic information on a regular basis.

 

Page Content

Healthcare Providers can access additional information here:

Information for Providers

Oral Antiviral Treatments

PAXLOVID


Paxlovid is authorized for treatment of mild to moderate COVID-19 in adults and pediatric patients age 12 years and older with a positive SARS-CoV-2 test. Renal Paxlovid is a different dosing regimen of Paxlovid that is used for patients who have moderately impaired renal function.

LAGEVRIO

Molnipiravir (LAGEVRIO) is for treating adults age 18 years and older, who are at high risk for progressing to severe COVID-19 and for whom alternative COVID-19 treatment options are not accessible or clinically appropriate.

Infusion Antiviral Treatment

REMDESIVIR (Veklury)

Veklury (remdesivir) is an antiviral drug for the treatment of adults and pediatric patients with a positive SARS-CoV-2 test who are at high risk for progression to severe COVID-19, including hospitalization or death.

Veklury is administered as an IV infusion over the course of 3 days and should be initiated within 7 days of symptom onset.

 
COVID-19 Test to Treat Program

Test to Treat is a new nationwide initiative where people will be able to get tested and – if they are positive access treatments all in one location. These “One-Stop Test to Treat” locations will be available at hundreds of locations nationwide, follow the link below. People can also be tested and treated by their own health care providers who can appropriately prescribe oral antivirals.

 How to Protect Yourself and Others

There are steps you can take to protect yourself, your household, and your community from severe illness from COVID-19.  These include staying up to date on vaccination, getting tested for COVID-19 if you are symptomatic, and seeking treatment if you test positive.

CDC recommends individuals put together a COVID-19 plan so you have all the information you need on hand if you get sick with COVID-19.  Here is a link to the CDC COVID-19 Plan that can be downloaded, printed, and shared with your family, friends, and healthcare provider.

LINK TO  How to Protect Yourself and Others | CDC

LINK to COVID-19 PLAN:  COVID-19 Personal Plan (cdc.gov)


Connecticut Therapeutic News Spots

 Information for Patients

Center for Disease Control and Prevent

Department of Health and Human Services

Contact Information